Neptune Technologies & Bioressources, Inc. (NASDAQ:
NEPT) is a biotechnology company focused on the development and
commercialization of products derived from marine biomasses for the
nutraceutical and pharmaceutical industries. Leveraging a patented extraction
process, the company produces nutrient-rich oils from Antarctic krill, which
provide the foundation for its business dealings. Following extraction, Neptune
principally sells its krill oils under the NKO® brand through a network of
distributors doing business in the U.S., European and Australian nutraceutical
markets.
Since bringing its first krill oil product to market in
2003, Neptune has taken significant steps toward increasing its market share in
the global nutraceutical industry. The company’s proprietary extraction process
allows it to produce an oil with superior levels of EPA, DHA and antioxidants,
as compared to other krill oils. As a result, NKO products provide broad,
clinically proven support for a collection of health issues. In 2014, Neptune
expanded on these benefits by introducing three condition-specific oil blends –
including NKO Beat, NKO Focus and NKO Flex – specially formulated to support
heart, brain and joint health, respectively.
Last year, Neptune set the stage for continued market growth
by launching operations at its new manufacturing facility in Sherbrooke,
Quebec. The company’s new plant provides it with the means to address
manufacturing challenges unique to krill oil production, affording Neptune an
opportunity to optimize operational efficiency while promoting sustainable
financial growth. The new facility currently has an annual krill oil production
capacity of 150 metric tons, and the company has indicated that expansion
efforts could double this capacity in the future.
“Our business has a solid foundation, built on science,
intellectual property and entrepreneurship,” Jim Hamilton, president and chief
executive officer of Neptune, stated in a news release. “Our key priority is to
optimize our plant’s utilization, while producing the industry benchmark krill
oil, NKO.”
In the first quarter of 2015, Neptune built on its recent
progress by recording strong financial results. In addition to realizing a 10
percent year-over-year increase in revenue for the period, the company made
significant headway toward continued improvement by streamlining production
processes. For prospective shareholders, these efforts could foreshadow an
opportunity to realize considerable returns in the years to come. Look for
Neptune to continue expanding its effective production capacity in line with
increasing commercial demand moving forward.
For more information, visit www.neptunebiotech.com
About
MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
